Evidence map›Paper›PMID 39909884›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

Sustainable streptomycin-based Ag nanoparticle synthesis and study of the cytotoxicity.

Balázs Kakasi, Flóra Judit Varga, Márk Hopotószki, Erik Hopotószki, Imran Uddin

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Balázs KakasiAir Chemistry Research Group, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, 10. Egyetem Str., Veszprém, 8200, Hungary.
Flóra Judit VargaAir Chemistry Research Group, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, 10. Egyetem Str., Veszprém, 8200, Hungary.
Márk HopotószkiAir Chemistry Research Group, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, 10. Egyetem Str., Veszprém, 8200, Hungary.
Erik HopotószkiAir Chemistry Research Group, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, 10. Egyetem Str., Veszprém, 8200, Hungary.
Imran UddinNanolab, Research Institute of Biomolecular and Chemical Engineering, University of Pannonia, 10. Egyetem Str., Veszprém, 8200, Hungary. uddin.imran@mk.uni-pannon.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is one of the major problems of our time, which can be addressed by the use of different nanoparticles synthesized using antibiotics. The interaction between nanoparticles and biological systems is dynamic, which makes them extremely powerful for applications in the biomedical field. In this work, silver nanoparticles (Ag NPs) were synthesized with streptomycin and characterized by TEM, XRD, and UV-VIS. The synthesis resulted in the formation of spherical particles in the size range of 10-20 nm, which did not show any signs of aggregation after several days, facilitating their ease of use. Cytotoxicity studies of the synthesized AgNPs were performed by flow cytometry on A549 lung cancer cells after 24 h of exposure. At a concentration of 0.02 mM AgNP, the live cell ratio did not differ significantly from the control, but LC

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsMetal NanoparticlesSilverStreptomycinA549 CellsCell SurvivalHumansMitochondriaParticle SizeAnti-Bacterial AgentsAntineoplastic AgentsSilverStreptomycinAntibioticBioinspiredCytotoxicityMitochondria activitySilver nanoparticlesStreptomycin

Identifiers

PMID39909884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.